Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
US8063225B2 · kind B2 · utility
10Cited by
2References
37Claims
0Family size
Assignee
Inventors
- Vlad Edward Gregor
- Yahua Liu
- Alexey Vyacheslavovich Anikin
- Danny Peter Claude McGee
- Charles Chamchoumis Mikel
- Douglas Eric McGrath
- Goverdhan Reddy Vavilala
- Jason C. Pickens
- Alexander Kadushkin
- Luyong Jiang
- Mohan Santhanam Thiruvazhi
- Sergey Zozulya
- Rajendran Vairagoundar
- Tong Zhu
- Alexander Chucholowski
- Thomas R. Webb
- Vidyasagar Reddy Gantla
- Zheng Yan
Key dates
| Filing date | Aug 10, 2007 |
| Grant date | Nov 22, 2011 |
| Priority date | — |
| Expiry date | Dec 10, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are compounds of the formula (I):or a stereoisomer, tautomer, salt, hydrate or prodrug thereof that modulate tyrosine kinase activity, compositions comprising the compounds and methods of their use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.